Abstract:Since the recent outbreak of COVID-19, there have been intense efforts to understand viral pathogenesis and host immune response to combat SARS-CoV-2. It has become evident that different host alterations can be identified in SARS-CoV-2 infection based on whether infected cells, animal models or clinical samples are studied. Although nasopharyngeal swabs are routinely collected for SARS-CoV-2 detection by RT-PCR testing, host alterations in the nasopharynx at the proteomic level have not been systematically investigated. Thus, we sought to characterize the host response through global proteome profiling of nasopharyngeal swab specimens. A mass spectrometer combining trapped ion mobility spectrometry (TIMS) and high-resolution QTOF mass spectrometer with parallel accumulation-serial fragmentation (PASEF) was deployed for unbiased proteome profiling. First, deep proteome profiling of pooled nasopharyngeal swab samples was performed in the PASEF enabled DDA mode, which identified 7723 proteins that were then used to generate a spectral library. This approach provided peptide level evidence of five missing proteins for which MS/MS spectrum and mobilograms were validated with synthetic peptides. Subsequently, quantitative proteomic profiling was carried out for 90 individual nasopharyngeal swab samples (45 positive and 45 negative) in DIA combined with PASEF, termed as diaPASEF mode, which resulted in a total of 5023 protein identifications. Of these, 577 proteins were found to be upregulated in SARS-CoV-2 positive samples. Functional analysis of these upregulated proteins revealed alterations in several biological processes including innate immune response, viral protein assembly, and exocytosis. To the best of our knowledge, this study is the first to deploy diaPASEF for quantitative proteomic profiling of clinical samples and shows the feasibility of adopting such an approach to understand mechanisms and pathways altered in diseases.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jproteome.1c00506.Distribution of protein identified in multiple samples and enriched canonical pathways, representative example of detected viral peptide AYNVTQAFGR, and the top scoring networks in IPA (PDF)Mass spectrometry settings of diaPASEF experiment (XLSX)Spectral library used for interpretation of diaPASEF data (XLSX)List of proteins quantified from 90 diaPASEF experiments (XLSX)This article has not yet been cited by other publications.

CoVProt: Toward a Mass Spectrometry Data Portal for COVID-19 Proteomics Research and Development

OverCOVID: an Integrative Web Portal for SARS-CoV-2 Bioinformatics Resources

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.

CoVM2: Molecular Biological Data Integration of SARS-CoV-2 Proteins in a Macro-to-Micro Method.

A Bioinformatics Approach to Mine the Microbial Proteomic Profile of COVID-19 Mass Spectrometry Data

COVIDpro: Database for Mining Protein Dysregulation in Patients with COVID-19

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?

Diving into the proteomic atlas of SARS-CoV-2 infected cells

Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics

DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients

A time-resolved proteomic and prognostic map of COVID-19

SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets

Serum proteomics for the identification of biomarkers to flag predilection of COVID19 patients to various organ morbidities

Proteomics Research of SARS-CoV-2 and COVID-19 Disease

Coronavirus Immunotherapeutic Consortium Database

Blood proteomics of COVID-19 infection: An update

A targeted LC-MRM 3 proteomic approach for the diagnosis of SARS-CoV-2 infection in nasopharyngeal swabs

Proteomic Profiling of COVID-19 Patients Sera: Differential Expression with Varying Disease Stage and Potential Biomarkers

Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives

vPro-MS enables identification of human-pathogenic viruses from patient samples by untargeted proteomics